CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$55.43 -0.01 (-0.02%)
At close: Oct 2, 2026 · 4:00 PM EDT

CRISPR Therapeutics AG (CRSP) Return on Capital Employed [ROCE] (2016 - 2026)

Updated

CRISPR Therapeutics AG's Return on Capital Employed [ROCE] came in at -20.91% for Q2 2026, up 6.80 percentage points from -27.71% a year earlier and up 6.49 percentage points from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) Return on Capital Employed [ROCE] (2016 - 2026) Analysis & Trends

For FY2025, CRISPR Therapeutics AG's Return on Capital Employed [ROCE] was -31.58%, down 9.86 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of -5.38 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -21.72% in FY2024 (-11.26 pp), -10.46% in FY2023 (+17.87 pp), -28.33% in FY2022 (-45.54 pp) and 17.21% in FY2021 (+43.41 pp).
  • The Q2 2026 figure represents the highest quarterly Return on Capital Employed [ROCE] since Q3 2024.
  • Year-over-year, Return on Capital Employed [ROCE] increased in two of the last eight quarters, with an average year-over-year change of -5.93 percentage points.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q4 2021 (a gain of 36.69 percentage points), and the weakest in Q2 2022 (a drop of 45.48 percentage points).
  • Business Quant data shows CRSP's Return on Capital Employed [ROCE] at -27.40% (Q1 2026), -31.55% (Q4 2025) and -28.46% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 CRISPR Therapeutics AG 5.36 Bn 5.36 Bn - -20.91%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -20.91%
Mar 31, 2026 -27.40%
Dec 31, 2025 -31.55%
Sep 30, 2025 -28.46%
Jun 30, 2025 -27.71%
Mar 31, 2025 -22.76%
Dec 31, 2024 -21.59%
Sep 30, 2024 -15.05%
Jun 30, 2024 -15.68%
Mar 31, 2024 -13.48%
Dec 31, 2023 -10.86%
Sep 30, 2023 -20.86%
Jun 30, 2023 -22.69%
Mar 31, 2023 -26.79%
Dec 31, 2022 -30.92%
Sep 30, 2022 -30.45%
Jun 30, 2022 -26.25%
Mar 31, 2022 12.17%
Dec 31, 2021 14.01%
Sep 30, 2021 14.88%
API Access

CRISPR Therapeutics AG Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CRSP&period=max&api_key=YOUR_API_KEY